Moderna Therapeutics modernatx.com


Public lists: Unicorns - Billion Dollar Startups (187)

Moderna Therapeutics is pioneering messenger RNA Therapeutics, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This platform addresses currently undruggable targets and offers a superior alternative to existing drug modalities for a wide range of disease conditions. Moderna has developed a broad intellectual property estate, including more than 200 patent applications with more than 10,00...Show all

Moderna Therapeutics is pioneering messenger RNA Therapeutics, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This platform addresses curren...Show all

Company (Alive / Active)

Phone: 617-714-6500

Fax:

200 Technology Square

Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Moderna Therapeutics $1341.7M Sep 7, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Moderna Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins Feb 12, 2016 Feb 21, 2017 Patent
In vivo production of proteins Aug 12, 2015 Feb 21, 2017 Patent
Delivery and formulation of engineered nucleic acids Jul 22, 2014 Jan 03, 2017 Patent
Enzymes and polymerases for the synthesis of rna Aug 13, 2013 Dec 06, 2016 Patent
Modified polynucleotides for the production of nuclear proteins Dec 18, 2015 Nov 29, 2016 Patent
See all 119 patents